CXCL13-mediated NF-κB activation in B cells induces LT secretion, which enhances leukocyte infiltration and metastatic potential via the IKKα–BMI1 axis, particularly in androgen-deprived prostate cancer [337–339]. Here, CXCL13 is linked to prostate carcinoma.